Once you've reached your goal (or a weight you're comfortable maintaining) the next question is whether you need to stay on your current dose. Research and community experience both suggest that many people don't.

The data.

A study published in Obesity found that 80.8% of patients maintained their weight loss on a reduced dose of semaglutide. This means most people can step down without losing their results.

The key phrase is "lowest effective dose": the smallest amount of medication that keeps your appetite managed and weight stable.

Worth remembering
80.8% of patients maintain their weight loss on a reduced dose. The right maintenance level is usually below your peak, and finding it is a process of stepping down and watching, not all at once.

The taper strategy.

The community consensus: the people with the best long-term results didn't quit cold turkey. They stepped down gradually, held at each lower dose for weeks, and monitored their hunger and weight before stepping down again.

A common approach:

  1. Reach your goal weight (or close to it) at your current dose
  2. Hold for 2-3 months to let your body stabilize at the new weight
  3. Step down one dose level (e.g., 2.4 mg → 1.7 mg → 1.0 mg)
  4. Hold for 4-8 weeks at each reduced dose, monitoring weight and appetite
  5. Stop reducing when you find the dose where weight stays stable and food noise stays manageable
  6. Consider staying at that maintenance dose long-term

Finding your lowest effective dose.

Signs you've gone too low:

Signs you're at the right level:

The long-term view.

Some people taper all the way off and maintain through habits alone. Others find a low maintenance dose (0.25-0.5 mg semaglutide, 2.5-5 mg tirzepatide) that they stay on indefinitely. Neither approach is "better." The right choice depends on your individual biology and response.

Read next What happens when you stop

Sources

  1. REVIEWLess frequent dosing as maintenance strategy (Wiley Obesity)
  2. COHORTReal-world titration and persistence (Wiley DOM)
  3. COHORTWeight changes by discontinuation status (PMC)
  4. RCTSTEP 1 trial extension: weight regain after semaglutide withdrawal (PMC)
  5. FDAWegovy FDA Prescribing Information (2025)

This article is for educational purposes only and is not medical advice. Never adjust medication doses without consulting your healthcare provider.